Axsome Therapeutics, Inc.

Contributing Author

Recent Articles by Axsome Therapeutics, Inc.

May-28	Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting AXSM GlobeNewswire
May-27	Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Hetero Labs Ltd. AXSM GlobeNewswire
May-13	Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone AXSM GlobeNewswire
May-05	Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update AXSM GlobeNewswire